Newsroom

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Summary Bayer today announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to reduce urinary albumin-to-creatinine ratio (UACR), which is expected to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline and end-stage kidney disease in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D), following the agency’s Priority Review of the supplemental New Drug Application (...

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 16 September 2026 COMPANY ANNOUNCEMENT Immediate Release 16 September 2026 DB ETC plc (the Issuer) (incorporated and registered in Jersey under the Companies (Jersey) Law 1991 (as amended) with registered number 103781) Re: Value per Security of ETC Securities Announcement The Issuer is providing the Value per Security for the ETC Securities for the following Series as set out in the table below for 15 September 2026 Series ISIN Currency Value per Se...

LONDON--(BUSINESS WIRE)--  Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value and Year-To-Date Return As Of 15 September 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today released its regular weekly Net Asset Value (“NAV”) and performance returns on its website, https://pershingsquareholdings.com/performance/net-asset-value-and-returns/. The NAV and returns were computed as of the close of business on Tuesday, 15 September 2026. PSH NAV per share as of close of bu...

WESTMINSTER, Colo.--(BUSINESS WIRE)--Vantor, the leader in unified spatial intelligence, today announced it has selected EnduroSat and CACI to develop and build the initial Vantor Pulse™ satellites, a fleet of 40 cm-class satellites designed to image the same location on Earth as often as every 15 minutes. Pulse will provide frequent, broad-area monitoring and feed Tensorglobe™, Vantor’s spatial intelligence platform, where its data can be fused with AI, 3D data, and high-resolution imagery to...

LONDON--(BUSINESS WIRE)--  DB ETC PLC Dated: 16 September 2026 COMPANY ANNOUNCEMENT Immediate Release 16 September 2026 DB ETC plc (the Issuer) Law 1991 (as amended) with registered number 103781) Re: Issuance of ETC Securities Announcement The Issuer has agreed to issue ETC Securities for the following Series as set out in the table below. Series Tranche Number of Securities to be issued Trade Date Settlement Date ISIN: Series 04 - Xtrackers Physical Silver EUR Hedged ETC   456 4,000 14 Septem...

LONDON--(BUSINESS WIRE)--  Consort Healthcare (Birmingham) Funding GBP398,680,000 1.972per cent Index Linked Guaranteed Secured Bonds due 2044 ISSUE NAME. Our Ref. B24317 ISIN Code. XS0257525112 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. Actual/Actual ISMA (A006) NUM OF DAYS. 183 INTEREST RATE. 0 PCT VALUE DATE. 30/09/2026 INTEREST PERIOD. 31/03/2026 TO 30/09/2026 GBP 1,000.00 IS GBP 12.88 POOL FACTOR. 0.6215490...

ROME--(BUSINESS WIRE)--The Mediterranean Network for Haemoglobinopathies (MNfH) was recently launched at Palazzo Wedekind in Rome, bringing together leading clinicians and patient representatives from Cyprus, Greece, and Italy, with the Thalassaemia International Federation (TIF). Supported by Avanzanite Bioscience as Founding Sponsor, the independent regional platform will connect expertise across borders, strengthen the patient voice, and turn shared knowledge into practical initiatives that...

ATLANTA--(BUSINESS WIRE)--NCR Atleos Corporation (NYSE: NATL) (“Atleos”), a leader in expanding self-service financial access for financial institutions, retailers and consumers, today announced that Bank Pekao S.A., one of the largest financial institutions in Central and Eastern Europe, has selected the Atleos Authentic™ payment switching platform as part of its card payment processing infrastructure modernization strategy. Under the agreement, Atleos will provide its Authentic switch platfor...

LONDON--(BUSINESS WIRE)--  Consort Healthcare (Mid Yorkshire) Funding GBP214,531,000 2.055per cent Index Linked Guaranteed Secured Bonds due 2041 (incl GBP43,000,000 Variation Bonds) ISSUE NAME. Our Ref. B38689 ISIN Code. XS0307799246 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. Actual/Actual ISMA (A006) NUM OF DAYS. 183 INTEREST RATE. 0 PCT VALUE DATE. 30/09/2026 INTEREST PERIOD. 31/03/2026 TO 30/09/2026 GBP 1,000.00 IS GBP 11.74 POOL FACTOR. 0.5632330...

FRANKFURT AM MAIN, Germany--(BUSINESS WIRE)--Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has received approval in the European Union (EU) / European Economic Area (EEA) for XEOMIN® (incobotulinumtoxinA) for the symptomatic treatment of spasticity associated with pes equinus, a condition in which tight calf muscles cause the foot to point downward, in ambulant and non-ambulant children and adolescents with cerebral palsy (CP) aged 2 to 17 ye...